A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

NCT01843621 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: DEN vaccine F17

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]